Literature DB >> 28350941

Spine Oncology - Primary Spine Tumors.

Nicolas Dea1, Ziya Gokaslan2, David Choi3, Charles Fisher4.   

Abstract

Primary tumors originating from the spine are very complex and challenging entities to treat. Due to their rarity, a multicenter collaborative network is essential to shepherd the best research and contribute to the dissemination of the best evidence possible. Over the last few years, several advances have occurred in many different fields. Surgery is still the cornerstone of treatment in most cases. The occasional suboptimal outcomes and high morbidity of surgical treatment have however encouraged professionals caring for these patients to explore safer treatment options and alternatives or adjuncts to surgical treatment. A number of novel treatment strategies have emerged from the medical, interventional radiology, radiation oncology, and molecular worlds. This has truly positioned primary spine tumors at the forefront of multidisciplinary care. This article discusses these recent advances in detail to equip the oncologic spine surgeon and their team to better counsel and treat these patients. Most of these advances allow for a more tailored, efficient, and, most importantly, less morbid management of primary spine tumors. Some of these advances are still under investigation, however, and evidence-based oncological principles should still be strongly encouraged.
Copyright © 2016 by the Congress of Neurological Surgeons.

Entities:  

Keywords:  En bloc resection; Interventional radiology; Medical treatment; Molecular sequencing; Mrimary spine tumors; Radiation oncology; surgery

Mesh:

Year:  2017        PMID: 28350941     DOI: 10.1093/neuros/nyw064

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  Pathological Clinical Analysis and Imaging Manifestations for Spinal Bone Tumors Based on Cement Injection.

Authors:  Jie Li; Xu Wang; Yongmin Li; Qinhui Cao; Yi Bu; Hengcong Cao; Xiaoqiang Wang
Journal:  Appl Bionics Biomech       Date:  2022-04-25       Impact factor: 1.664

Review 2.  Recent advances in intradural spinal tumors.

Authors:  Muhammad M Abd-El-Barr; Kevin T Huang; Ziev B Moses; J Bryan Iorgulescu; John H Chi
Journal:  Neuro Oncol       Date:  2018-05-18       Impact factor: 12.300

Review 3.  Surgical Management of Skull Base and Spine Chordomas.

Authors:  Joel Z Passer; Christopher Alvarez-Breckenridge; Laurence Rhines; Franco DeMonte; Claudio Tatsui; Shaan M Raza
Journal:  Curr Treat Options Oncol       Date:  2021-03-20

Review 4.  Recent advances and new discoveries in the pipeline of the treatment of primary spinal tumors and spinal metastases: a scoping review of registered clinical studies from 2000 to 2020.

Authors:  Julio C Furlan; Jefferson R Wilson; Eric M Massicotte; Arjun Sahgal; Michael G Fehlings
Journal:  Neuro Oncol       Date:  2022-01-05       Impact factor: 13.029

5.  Logistic regression analysis of risk factors for postoperative recurrence of spinal tumors and analysis of prognostic factors.

Authors:  Shanyong Zhang; Lili Yang; Chuangang Peng; Minfei Wu
Journal:  Oncol Lett       Date:  2017-12-04       Impact factor: 2.967

6.  Coexpression of HHLA2 and PD-L1 on Tumor Cells Independently Predicts the Survival of Spinal Chordoma Patients.

Authors:  Chao Xia; Wei Huang; Yun-Liang Chen; Hai-Bin Fu; Ming Tang; Tao-Lan Zhang; Jing Li; Guo-Hua Lv; Yi-Guo Yan; Zhi-Hua Ouyang; Nvzhao Yao; Cheng Wang; Ming-Xiang Zou
Journal:  Front Immunol       Date:  2022-01-25       Impact factor: 7.561

Review 7.  Interventional Radiology in the Management of Metastases and Bone Tumors.

Authors:  Ferruccio Sgalambro; Luigi Zugaro; Federico Bruno; Pierpaolo Palumbo; Nicola Salducca; Carmine Zoccali; Antonio Barile; Carlo Masciocchi; Francesco Arrigoni
Journal:  J Clin Med       Date:  2022-06-07       Impact factor: 4.964

8.  Customized Multilevel 3D Printing Implant for Reconstructing Spine Tumor: A Retrospective Case Series Study in a Single Center.

Authors:  Zhengwang Sun; Mengchen Yin; Yueli Sun; Mo Cheng; Meng Fang; Wending Huang; Junming Ma; Wangjun Yan
Journal:  Orthop Surg       Date:  2022-07-27       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.